Testosterone and its derivatives play a key role in the development and progression of prostate cancer, driving tumour growth and spread. While hormonal therapies effectively control the disease, resistance often develops, requiring new, innovative treatments. Ongoing research into hormonal pathways promises more targeted therapies, enhancing patient outcomes and quality of life.
